News
Abcuro Initiates Part B of Registrational Phase 2/3 MUSCLE Clinical Trial of Ulviprubart (ABC008) for the Treatment of Inclusion Body Myositis November 13, 2023 07:00 AM Eastern Standard Time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback